13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
NCT02786836
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class
Conditions
Acute Liver Failure
Interventions
DRUG:
13C-Methacetin
Sponsor
University of Texas Southwestern Medical Center
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]